Search

You searched for "EURETINA"

1491 results found

Grading of ocular inflammation in uveitis: an overview

1 February 2016 | | EYE - Vitreo-Retinal
Anterior uveitis is the commonest form of uveitis, which can lead to severe morbidity if not treated appropriately [1]. Data from general ophthalmology practices suggest around 90% of uveitis encountered by comprehensive ophthalmologists is anterior uveitis [2]. Intermediate (vitreous), posterior...

The ROP Network: a south-south collaboration to improve care for premature babies

4 October 2023 | | EYE - Paediatrics, EYE - Strabismus
Retinopathy of prematurity (ROP) is a disorder of the immature preterm retina and a leading cause of preventable, irreversible blindness in children. There are 15 million preterm births annually, and over 32,000 neonates became blind from ROP in 2010 [1]....

100% Ophthalmology Programme Insights

24 February 2024 | | 100%, ophthalmology, Conferences, London, events, optical, optometrist
We spoke to some of the Eye News family about their upcoming presentations at 100% Opthalmology, 24–26 February 2024, ExCeL London, UK.

Chemical injury

6 April 2021 | | EYE - Cornea, EYE - General
You are the on-call ophthalmologist. You receive a call from A&E regarding a 45-year-old man who sustained a chemical injury. He was mixing some cement, when a small amount entered his left eye. He was not wearing any protective goggles....

What's trending Oct/Nov 2022

3 October 2022 | | EYE - Vitreo-Retinal, EYE - General
A round-up of the eye related hot topics that have been trending on social media over the last few weeks. #teammates #warringtonwolves #keratoconus Robbie Mulhern, a professional rugby league player for Warrington Wolves, had never heard of keratoconus prior to...

Blind Faith: In Conversation with Mariya Moosajee

16 August 2023 | EYE - General
In light of the BBC releasing Blind Faith: Do genetic eye disease ‘treatments' work? earlier this year, a documentary which follows BBC journalist Ramadan Younes as he investigates practitioners who falsely claim to have ‘treatments’ for genetic eye disease, Eye...

Doctor at large

1 October 2021 | | EYE - Vitreo-Retinal, EYE - General
“In 1930, the Republican-controlled House of Representatives, in an effort to alleviate the effects of the… Anyone? Anyone?... the Great Depression, passed the… Anyone? Anyone? The tariff bill? The Hawley-Smoot Tariff Act? Which, anyone…?” In this memorable scene, the monotonous...

A glimpse of Syrian ophthalmology

5 August 2026 | | EYE - General
Ophthalmology training in Syria has long followed a rigorous residency model, preparing medical graduates for specialist practice through surgical experience and formal examinations. Yet in recent years, the combination of conflict, resource shortages and emigration of medical professionals has created...

From spine to eye: The benefits of multidisciplinary research

10 April 2025 | | EYE - Glaucoma, EYE - Neuro-ophthalmology
What have spinal and vision research got in common? More than you’d think. Dr Richard Eva. Funded by Fight for Sight, Dr Richard Eva came to vision from spinal cord research and is now co-lead on a project related to...

My Top Five: Preparing for the Duke Elder examination: My tips for success

3 June 2026 | | EYE - General
The Duke Elder Examination is a prestigious ophthalmology exam, open to all medical undergraduates. It is a prize examination, consisting of 90 multiple-choice questions in two hours, testing students on ophthalmology content beyond the undergraduate curriculum. With notoriously tough questions,...

Retinopathy of prematurity treatment in the South West of England: long-term outcomes 1997-2008

1 December 2014 | | EYE - Vitreo-Retinal
Retinopathy of prematurity (ROP) is a condition that affects the developing retinal vascular system of pre-term babies. If left untreated, ROP can lead to severe visual impairment. The severe visual impairment caused by untreated ROP can be prevented by screening...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...